Diabetes Business ChallengesAHCO's diabetes business remains pressured, with management expecting declines in revenues through 2025, impacting EBITDA growth.
Revenue And EBITDA GuidanceAdaptHealth reduced its FY'25 guidance ranges, reflecting a decrease in expected revenue and adjusted EBITDA due to the divestiture.
Segment PerformanceNew challenges in sleep entered the picture this quarter, with competitors gaining share in a few states.